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Abstract 
A large number of genetic loci are associated with adult body mass index. However, the genetics 
of childhood body mass index are largely unknown. We performed a meta-analysis of genome-
wide association studies of childhood body mass index, using sex- and age-adjusted standard 
deviation scores. We, included 35,668 children from 20 studies in the discovery phase and 
11,873 children from 13 studies in the replication phase. In total, 15 loci reached genome-wide-
significance (P-value < 5 x 10-8) in the joint discovery and replication analysis, of which 12 are 
previously identified loci in or close to ADCY3, GNPDA2, TMEM18, SEC16B, FAIM2, FTO, 
TFAP2B, TNNI3K, MC4R, GPR61, LMX1B and OLFM4 associated with adult body mass index 
or childhood obesity. We identified three novel loci: rs13253111 near ELP3, rs8092503 near 
RAB27B, and rs13387838 near ADAM23. Per additional risk allele, body mass index increased 
0.04 Standard Deviation Score (SDS) (Standard Error (SE) 0.007), 0.05 SDS (SE 0.008) and 
0.14 SDS (SE 0.025), for rs13253111, rs8092503, and rs13387838, respectively. A genetic risk 
score combining all 15 SNPs showed that each additional average risk allele was associated with 
a 0.073 SDS (SE 0.011, P-value = 3.12 x 10-10) increase in childhood body mass index in a 
population of 1,955 children. This risk score explained 2% of the variance in childhood body 
mass index. This study highlights the shared genetic background between childhood and adult 
body mass index and adds three novel loci. These loci likely represent age-related differences in 
strength of the associations with body mass index. 
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Introduction 
Childhood obesity is an important public health problem with severe consequences, including an 
increased risk of premature death (1-5). Body mass index (BMI) has a strong genetic component 
with some reported heritability estimates being over 80% (6-8). Large genome-wide association 
studies (GWAS) have revealed many genetic loci associated with BMI or adiposity in adults (9-
13). However, the genetic loci underlying BMI in children are less well known. The biological 
background of BMI may differ between children and adults. In addition, it may be that the 
relative contributions of the same genetic loci differ depending on age, for example due to 
different gene-environment-interactions or body fat distributions (6, 14, 15). A limited number of 
loci has been identified to associate with dichotomous definitions of childhood obesity (16-18). 
Also, the roles of specific known adult loci for BMI, such as FTO and ADCY3, have been 
described in children (13, 19). The age-specific effects are illustrated by longitudinal studies on 
the effects of the well-known adult BMI increasing risk allele of FTO with BMI throughout 
childhood (15). It has been reported that adult BMI increasing risk allele is associated with lower 
BMI in infancy, an earlier adiposity rebound and a higher BMI from the age of five years 
onwards (14, 15, 20). To date, studies did not present a large GWAS meta-analysis on the full 
spectrum of childhood BMI (13, 16-19).  
To identify genetic loci influencing childhood BMI, we meta-analyzed 20 GWAS with a 
total of 35,668 children of European ancestry, combining data for around 2.5 million single 
nucleotide polymorphisms (SNPs) imputed to the HapMap imputation panel. We used as 
outcome sex- and age-adjusted standard deviation scores at the oldest age between 2 and 10 
years. 
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Results 
Study characteristics are shown in Supplementary Material, Table S1. Childhood BMI was 
transformed into sex- and age-adjusted standard deviation scores (SDS) (LMS growth; Pan H, 
Cole TJ, 2012. http://www.healthforallchildren.co.uk).  
 
Meta-analysis of genome-wide association studies 
Inverse-variance weighted fixed-effects meta-analysis revealed 861 SNPs with genome-wide 
significant or suggestive P-values (< 5 x 10-6). Two SNPs with high heterogeneity were not 
followed up (I2 values of 89.4 and 96.0), leaving 859 SNPs representing 43 loci. A locus was 
defined as a region of 500 kb to either side of the most significant SNP. The Manhattan and 
Quantile-Quantile plots of the discovery meta-analysis are shown in Figure 1 and Supplementary 
Material, Figure S1, respectively. The lambda for the discovery meta-analysis was 1.10. LD 
score regression analysis showed that this slight inflation was mainly due to polygenicity of the 
trait, rather than to population stratification, cryptic relatedness or other confounding factors 
(intercept 1.01). Individual study lambdas are shown in Supplementary Material, Table S2. All 
43 loci were taken forward for replication in a sample of 11,873 children from 13 studies. Table 
1 and Supplementary Material, Tables S3 and S4 show the results of the discovery, replication, 
and joint analyses for the 43 genome-wide and suggestive loci.  
In total, 15 of these reached genome-wide significance in the joint analysis. Twelve out 
of these 15 had been reported previously for related phenotypes. SNPs in or close to ADCY3, 
GNPDA2, TMEM18, SEC16B, FAIM2, FTO, TFAP2B, TNNI3K, MC4R, GPR61, LMX1B and 
OLFM4 are associated with adult BMI or childhood obesity (11, 13, 16). We identified three 
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novel loci: rs13253111 near ELP3, rs8092503 near RAB27B, and rs13387838 near ADAM23. Per 
additional risk allele, BMI increased 0.04 Standard Deviation Score (SDS) (Standard Error (SE) 
0.007), 0.05 SDS (SE 0.008) and 0.14 SDS (SE 0.025), for rs13253111, rs8092503, and 
rs13387838, respectively. Figure 2 and Supplementary Material, Figure S2 show the regional 
plots and the forest plots, respectively, for these loci.  
 
Genetic risk score 
We combined the 15 identified genome-wide significant SNPs into a genetic risk score that 
summed the number of BMI-increasing alleles weighted by their betas from the discovery 
analysis and rescaled to a range of 0 to 30, which is the maximum number of risk alleles. The 
risk score was associated with childhood BMI (P-value = 3.12 x 10-10) in 1,955 children from the 
PIAMA Study, one of our largest replication cohorts. For each additional average risk allele in 
the score, childhood BMI increased by 0.073 SDS (SE 0.011) (Figure 3). This risk score 
explained 2.0% of the variance in childhood BMI.  
 
Associations with adult body mass index and childhood obesity 
The genetic correlation between childhood BMI and adult BMI was 0.73. A lookup of the 15 
SNPs associated with childhood BMI in a recently published GWAS meta-analysis on adult BMI 
in more than 300,000 participants, revealed that all SNPs showed evidence for association were 
nominally significantly associated with adult BMI, with P-values of 0.005, 5.76 x 10-5 and 0.003 
for the novel SNPs rs13253111, rs8092503 and rs13387838, respectively. Also, the direction of 
the effect estimates for all 15 SNPs was the same in children and adults (Supplementary 
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14 
Material, Table S5) (11). The 15 SNPs found in this study explained 0.94% of the variance in 
adult BMI in the GIANT consortium (11).  
A reverse lookup in our dataset of the 97 known genome-wide significant loci previously 
reported to be associated with adult BMI showed that 22 out of the 97 loci were significantly 
associated with childhood BMI index, using a Bonferroni-adjusted P-value cutoff of 5.2 x 10-4 
for 97 SNPs. A total of 50 out of the 97 known adult BMI SNPs were nominally associated with 
childhood BMI (P-value <0.05). The direction of the effect estimates was the same in adults and 
children for 86 SNPs (P-value binomial sign test <1.0 x 10-4; Supplementary Material, Table S6).  
We looked up the association of the three novel loci in a GWAS meta-analysis of 
childhood obesity. In this study, childhood obesity cases were defined as having a BMI ≥ 95th 
percentile, whereas childhood normal weight controls were defined as having a BMI < 50th 
percentile. This meta-analysis included 22 studies, of which 16 were also included in our current 
meta-analysis. All three SNPs were associated with childhood obesity ((P-values 0.01, 0.005, 
and 6.0 x 10-4 for rs13253111, rs8092503, and rs13387838, respectively) (16).  
 
Functional analysis 
To explore functionality, we first analyzed if the 15 identified SNPs affect messenger RNA 
expression (eQTLs). We analyzed eQTLs from peripheral blood samples from 5,311 individuals, 
which revealed two cis-eQTLs (false discovery rate (FDR) P-value <0.05) for rs11676272, the 
top SNP in one of the previously identified loci (ADCY3). One of these eQTLs was for ADCY3, 
and one was for DNAJC27 (21). Also, we found a cis-eQTL for FAM125B for rs3829849, which 
is located in LMX1B (Supplementary Material, Table S76). eQTL analysis in adipose tissue, a 
more specific target tissue in relation to BMI, from 856 healthy female twins in the MuTHER 
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resource in Genevar revealed two significant cis-eQTLs (distance to SNP < 1 Mb) for 
rs11676272, for transcripts of ADCY3 and POMC, with a Bonferroni-corrected P-value of < 
0.003 (22, 23). The association of rs11676272 with expression of ADCY3 was also validated in a 
second eQTL analysis in a smaller set of 206 lymphoblastoid cell lines (24). We did not identify 
eQTLs related to our three novel loci. 
 Second, we performed functional analyses with the tool Data-Driven Expression 
Prioritized Integration for Complex Traits (DEPICT) using all SNPs with a P-value < 1 x 10-5 in 
the discovery analysis (see Materials and methods for details) (25). Gene prioritization analysis 
did not show prioritized genes, nor did the gene set enrichment analysis reveal evidence for 
enriched reconstituted gene sets and genes near the associated SNPs were not found to enrich for 
expression in a panel of 2009 tissue and cell types (FDR< 0.05; Supplementary Material, Tables 
S87a, b and c).  
 
Discussion 
In this GWAS meta-analysis of childhood BMI among more than 47,000 children, we identified 
15 genome-wide significant loci, of which three loci, rs13253111 near ELP3, rs8092503 near 
RAB27B, and rs13387838 near ADAM23, have not been associated with adiposity related 
phenotypes before. 
Large GWAS have revealed many genetic loci associated with BMI or adiposity in adults (9-13). 
A recent meta-analysis in up to 339,224 individuals identified 97 BMI-associated loci, 
explaining 2.7% of the adult BMI variation. Pathway analyses showed that the central nervous 
system may play a large role in obesity susceptibility. The number of identified loci associated 
with BMI or obesity in childhood is scarce. Of the total of 15 loci associated with childhood BMI 
 at K
ing's College London on D
ecem
ber 3, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
16 
in the current study, 12 have previously been associated with adiposity outcomes in adults or 
children. All 12 loci are known to be associated with adult BMI (11). Also, eight loci, including 
those in or near ADCY3 (annotated to the nearby gene POMC in the previous paper), TMEM18, 
SEC16B, FAIM2, FTO, TNNI3K, MC4R and OLFM4, have previously been associated with 
childhood obesity (16). All three novel loci were nominally associated with the more extreme 
outcome of childhood obesity in a largely overlapping population of child cohorts (16).  
A recent meta-analysis of two studies showed that the known loci FTO, MC4R, ADCY3, 
OLFM4 are associated with BMI trajectories in childhood (26). Their findings also suggested 
that a locus annotated to FAM120AOS influences childhood BMI, which could not be replicated 
in the current study. The lead SNP in this locus, rs944990, had a P-value of 1.61 x 10-5 in the 
current analysis. These findings suggest that the overlap between the genetic background of 
childhood and adult BMI is relatively large, but not complete. 
Rs7550711 represents one of the 12 identified loci known to be associated with BMI or 
obesity in adults and children. Rs7550711 is a proxy for rs17024258 and rs17024393 (R2 0.8 
with both SNPs), which have previously been associated with adult obesity and BMI, 
respectively, and annotated with the GNAT2 gene. However, our proxy resides in GPR61, G 
protein-coupled receptor 61, the biology of which may be more relevant to BMI. Gpr61-deficient 
mice are obese and have hyperphagia, suggesting the role of Gpr61 in food intake regulation 
(27). Further studies, including expression studies in relevant human tissues, are needed to 
establish the causal genes underlying this association.  
We identified three loci, rs13253111 near ELP3, rs8092503 near RAB27B, and rs13387838 near 
ADAM23, which have not been associated with adiposity related phenotypes before in adulthood 
or childhood. The nearest genes to the novel loci have varying functions. ELP3, Elongator 
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Acetyltransferase Complex, subunit 3, has a potential role in the migration of cortical projection 
neurons and in paternal demethylation after fertilization in mice (28-30). RAB27B, RAS-
associated protein RAB27B, encodes a membrane-bound protein with a role in secretory vesicle 
fusion and trafficking. It has been associated with pituitary hormone secretion, regulation of 
exocytosis of digestive enzyme containing granules from pancreatic acinar cells, and with gastric 
acid secretion (31-33). Expression of ADAM23, A Disintegrin And Metalloproteinase Domain 
23, may influence tumor progression and brain development (34, 35). It has also been described 
to be expressed in mouse adipose tissue and to have a potential role in adipogenesis in vitro (36).  
Two of our novel loci, rs13253111 near ELP3 and rs13387838 near ADAM23, are close to 
rs4319045 and rs972540, respectively. Both these SNPs were reported as subthreshold results in 
the GWAS meta-analysis on adult BMI (11). However, the linkage disequilibrium between the 
SNPs in both pairs is very low (R2 ≤ 0.1 for both) suggesting that these SNPs may represent 
different signals. It is important to note that, although both SNPs reached genome-wide 
significance in the joint discovery and replication analysis, the P-values in the replication stage 
were non-significant. This lack of significance may be due to the smaller sample size and lower 
power. Also, the joint P-values were slightly higher than the discovery P-values. Heterogeneity 
between the discovery and the replication stages was low to moderate, with I2 values of 61.1 and 
27.8 for rs13253111 and rs13387838, respectively (P-values > 0.01 for both). These two signals 
need to be interpreted with some caution and further studies with larger sample sizes are needed 
to fully clarify the role of variants in these regions in the physiology of BMI.  
  Functional analysis showed cis-eQTLs for the lead SNPs in two of the known loci. 
Rs11676272 was associated with eQTLs in ADCY3 and DNAJC27, also known as RBJ. Both 
these genes have been associated with adult BMI before and the association of rs11676272 with 
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expression of ADCY3 has been previously described in childhood BMI (11, 13, 37). Rs3829849 
was associated with an eQTL in FAM125B, or MVB12B, multivesicular body subunit 12B. This 
gene encodes a component of ESCRT-I (endosomal sorting complex required for transport I), a 
plasma membrane complex with a role in vesicular trafficking, was recently described to be 
associated with intra-ocular pressure (38). However, the LD of our SNPs with the peak markers 
for the DNAJC27 (R2 0.11) and the FAM125B (R2 0.03) transcripts was low. Our analysis using 
DEPICT did not show enriched gene sets. This may reflect the relatively limited sample size in 
our analysis. Further studies are needed to determine the potential functional impact of all SNPs 
associated with childhood BMI. 
Using LD score regression analysis with our meta-analysis results and the results from 
the recently published GWAs meta-analysis on adult BMI as input, we found that the genetic 
correlation between childhood and adult BMI was high (11, 39). The variance in adult BMI 
explained by the 15 SNPs identified in this study was lower than in children. The novel SNPs 
reported in this study may represent loci that specifically influence childhood BMI, but not adult 
BMI. An alternative explanation is that the effect sizes of these loci may be larger in children 
than in adults, which may explain the discovery in childhood studies but not in adult studies (11). 
The large overlap between childhood and adult BMI loci suggests that many of these loci may 
not represent childhood-specific effects, but rather involvement of the same loci with differential 
effect sizes at different ages. Age-specific effects of genetic variants associated with BMI in 
children have been described for the FTO locus (15). However, longitudinal studies with 
multiple measurements of BMI are needed to confirm and quantify such varying effects with 
age. In discussing the genetic overlap between childhood and adult BMI, it needs to be noted 
that, because of the differences in body proportions and body fat distribution, childhood BMI 
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may be a different phenotype as compared to adult BMI. Our outcome was the conventional 
measure of BMI calculated as weight/height2. Especially in early childhood, higher orders of 
magnitude for height may be more appropriate. Results from a previously published GWAS 
study on childhood BMI in two of the cohorts included in the current meta-analysis suggest that 
the results for SNPs close to ADCY3 are different when higher orders of magnitude for height are 
being used (37). Further studies are needed to identify loci related to more specific and directly 
assessed measures of adiposity and body fat distribution in young children. 
In conclusion, we identified 15 loci associated with childhood BMI, of which three are 
novel. Our results highlight a considerable shared genetic background between childhood and 
adult BMI. The novel BMI-related loci may reflect childhood-specific genetic associations or 
differences in strength of associations between age groups.  
 
Materials and methods 
Study populations  
Characteristics of each discovery and replication study population can be found in 
Supplementary Material, Table S1 and Supplementary Methods. The discovery analysis included 
20 studies with an age range from 3 to 10 years: the Avon Longitudinal Study of Parents and 
Children (ALSPAC, 6887 children), the Children’s Hospital of Philadelphia (CHOP, 2456 
children), the Copenhagen Studies on Asthma in Childhood 2000 birth cohort (COPSAC2000, 
309 children), the Danish National Birth Cohort (DNBC, 1020 children), the Generation R Study 
(GenerationR, 2226 children), the GOYA Study (GOYA, 199 children), the Helsinki Birth 
Cohort Study (HBCS, 1674 children), the INfancia y Medio Ambiente Project (INMA, 756 
children), the Leipzig study (Leipzig, 555 children), the Lifestyle – Immune System – Allergy 
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Study plus German Infant Study on the influence of Nutrition Intervention (LISA+GINI, 1147 
children), the Manchester Asthma and Allergy Study (MAAS, 801 children), the Norwegian 
Mother and Child Cohort Study (MoBa, 126 children), the Northern Finland Birth Cohort 1966 
(NFBC 1966, 3948 children), the Northern Finland Birth Cohort 1986 (NFBC 1986, 4000 
children), the Netherlands Twin Register (NTR, 1810 children), the Physical Activity and 
Nutrition in Children Study (PANIC, 423 children), the Western Australian Pregnancy Cohort 
(Raine) Study (Raine, 1458 children), the Special Turku coronary Risk factor Intervention 
Project (STRIP, 569 children), the Young Finns Study (YFS, 1134 children), the British 1958 
Birth Cohort Study, with two subcohorts which were entered into the meta-analysis separately 
(1958BC-T1DGC, 1974 children, and 1958BC-WTCCC2, 2196 children).  
We included 13 replication studies. Eleven of these were cohort studies: 574 children 
from the Copenhagen Studies on Asthma in Childhood 2010 birth cohort (COPSAC2010), 676 
additional children from the DNBC, 386 additional children from LISA+GINI, 3152 children 
from the TEDS Study, 1955 children from the Prevention and Incidence of Asthma and Mite 
Allergy birth cohort study (PIAMA), 1665 children from the BREATHE Study, 447 children 
from the Bone Mineral Density in Childhood Study (BMDCS), 200 children from the TEENs of 
Attica: Genes and Environment (TEENAGE) study, additional imputed data on 857 children 
from the Leipzig Study, 480 additional children from PANIC, and additional imputed data for 
569 children from STRIP. We also included two obesity case-control studies in the replication: 
the Danish Childhood Obesity Biobank (306 cases, 158 controls) and the French Young Study 
(304 cases, 144 controls). In the BREATHE Study, information was available about six SNPs 
only (rs8046312, rs12429545, rs13130484, rs3845265, rs543874, rs8084077).  
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All included children were of European ethnic origin. Sex- and age-adjusted standard 
deviation scores were created for BMI at the latest time point (oldest age, if multiple 
measurements existed) between 2 and 10 years using the same software across all studies (LMS 
growth; Pan H, Cole TJ, 2012. Available from: http://www.healthforallchildren.co.uk). 
Syndromic cases of obesity and children of non-European ethnic origin were excluded. In the 
case of twin pairs, only one twin was included, either randomly or based on genotyping or 
imputation quality. 
 
Statistical approach 
 Cohort-specific genome-wide association analyses were first run in the discovery cohorts, using 
high-density Illumina or Affymetrix SNP arrays, followed by imputation to the HapMap CEU 
release 22 imputation panel. The MAAS study imputed to the combined 1000 Genomes (1000G) 
Pilot + HapMap 3 (release June 2010/Feb 2009) panel. Before imputation, studies applied study-
specific quality filters on samples and SNP call rate, minor allele frequency and Hardy-Weinberg 
disequilibrium (see Supplementary Material, Table S1 for details). Leipzig (discovery sample), 
NFBC1986, STRIP (discovery sample), and PANIC (discovery sample) contributed unimputed 
data from the Metabochip. Linear regression models assuming an additive genetic model were 
run in each study, to assess the association of each SNP with SDS-BMI, adjusting for principal 
components if this was deemed needed in the individual studies. As SDS-BMI is age- and sex-
specific, no further adjustments were made. Before the meta-analysis, we applied quality filters 
to each study, filtering out SNPs with a minor allele frequency below 1% and SNPs with poor 
imputation quality (MACH r2_hat <= 0.3, IMPUTE proper_info <= 0.4 or info <= 0.4). For 
studies contributing unimputed metabochip data to the discovery analysis, we excluded SNPs 
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with a SNP call rate < 0.95 or with a Hardy Weinberg Equilibrium P-value of ≤ 0.00001. We 
performed fixed effects inverse-variance weighted meta-analysis of all discovery samples using 
Metal (40). Genomic control was applied to every study before the meta-analysis. Individual 
study lambdas ranged from 0.985 to 1.077 (Supplementary Material, Table S2). The lambda of 
the discovery meta-analysis was 1.10. After the meta-analysis, SNPs for which information was 
available in only one study were removed. 
The final dataset consisted of 2,499,691 autosomal SNPs. The most significant SNP for 
each of 43 genome-wide significant or suggestive loci (P-value < 5 x 10-6) was taken forward for 
replication in 13 replication cohorts. A locus was defined as a region 500 kb to either side of the 
most significant SNP. All replication cohorts had in silico data available. One of them only had 
non-imputed data (BREATHE), two (TEENAGE and TEDS) had data imputed to HapMap 
release 22, one cohort (PANIC) used exome chip data and the other nine performed imputation 
to 1000G. The replication samples of the STRIP and Leipzig studies only contributed 20 and 21 
imputed SNPs, respectively, as the unimputed SNPs were part of the discovery analysis). Fixed 
effects inverse-variance meta-analysis was performed for these 43 SNPs combining the 
discovery samples and all replication samples, giving a joint analysis beta, standard error and P-
value (Table 1 and Supplementary Material, Table S2).  
 
Sensitivity analyses 
Allele frequency differences between the discovery and the replication samples were small and 
stayed within a range of seven percentage points for all SNPs, except for rs1573972, which had a 
minor allele frequency of 9% in the discovery analysis and 28% in the replication analysis. This 
was likely due to the inclusion of one study (MAAS) that had imputed to the combined 
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HapMap+1000G panel, whereas all other studies with imputed data had imputed to HapMap. To 
increase homogeneity, we performed several sensitivity analyses. First, we reran the discovery 
meta-analysis excluding the MAAS study. This analysis did not materially change our findings, 
with one additional SNP (rs10055577) reaching the subthreshold level of significance (P-value = 
1.10 x 10-6) and five SNPs (rs4870949, rs1838856, rs633143, rs10866069, and rs1573972) 
losing significance. None of these five SNPs had replicated in the primary analysis. Second, we 
reran the replication and joint meta-analysis including only those cohorts that imputed to 1000G. 
Results of this analysis were very similar to the primary analysis, with two additional replicated 
SNPs, rs17309930 near BDNF and rs13107325 in SLC39A8. Both of these are known loci for 
adult BMI (11, 13). Third, we reran the replication including only the HapMap-imputed and 
unimputed studies (TEDS, TEENAGE, and BREATHE). The results were very similar to those 
using all studies, with rs4870949 and rs2590942 now passing the significance threshold and 
rs8092503 and rs3829849 now just above it (results not shown). Rs1573972 was not replicated 
in any of the analyses. As results of the third and fourth sensitivity analyses were very similar to 
those including all replication cohorts, we used the latter as our main analysis for reasons of 
power. 
 
Genetic risk score and percentage of variance explained 
A weighted risk score was computed as the sum of the number of SDS-BMI-increasing alleles 
(dosage) weighted by the effect sizes from the discovery meta-analysis. Then, the score was 
rescaled to range from zero to the maximum number of SDS-BMI increasing alleles (30 alleles 
for 15 SNPs) and rounded to the nearest integer. The association of the risk score with SDS-BMI 
was assessed in one of the largest replication cohorts (PIAMA, N=1955) by running a linear 
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regression model. The variance in SDS-BMI explained by the risk score was estimated by the 
unadjusted R2 of this model. The percentage of variance in adult BMI explained by the 15 SNPs 
was calculated using the published data from the recently published large meta-analysis of 
GWAs studies on adult BMI (11). For each SNP, the variance explained was calculated as: 
2*(adult effect size^2)*MAF*(1-MAF) and these variances were then summed to give the total 
percentage of variance in adult BMI explained by the 15 SNPs (11, 41). 
 
LD score regression 
LD score regression was used with the standard settings (39). Changing the minor allele 
frequency filter from 0 to 0.05 did not change the results. Therefore, we report the results of the 
unfiltered analysis only.  
 
eQTL analysis  
eQTL analysis was conducted using most significant SNP from each of the 15 genome-wide 
significant loci from the joint analysis. There was no linkage disequilibrium between these SNPs. 
First, we assessed whether the top SNPs or their proxies, identified on the basis of R2 > 0.7, were 
associated with gene expression in whole-blood cells in a sample of 5,311 individuals (21). 
Expression in this dataset was assessed using Illumina Whole-Genome Expression BeadChips 
(HumanHT-12). eQTLs were deemed cis when the distance between the SNP chromosomal 
position and the probe midpoint was less than 250 kb. eQTLs were mapped using Spearman's 
rank correlation, using imputation dosage values as genotypes. A n FDR P-value of <0.05 was 
considered significant.  Second, the 15 SNPs were introduced to the online eQTL database 
Genevar (www.sanger.ac.uk/resources/software/genevar) to explore their associations with 
 at K
ing's College London on D
ecem
ber 3, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
25 
expression transcripts of genes in proximity (<1Mb distance) to the SNP in adipose tissue from 
856 healthy female twins of the MuTHER resource (22, 23). We used Bonferroni correction for 
the significance threshold (P-value< 0.003).  
 
Data-driven Expression Prioritized Integration for Complex Traits (DEPICT)(42)  
DEPICT was run using SNPs with P-value < 10-5 as yielding 56 independent DEPICT loci 
comprising 100 genes. DEPICT was run using default settings, that is using 500 permutations for 
bias adjustment, 20 replications for false discovery rate estimation, normalized expression data 
from 77,840 Affymetrix microarrays for gene set reconstitution (see (43) for details), 14,461 
reconstituted gene sets for gene set enrichment analysis, and testing 209 tissue/cell types 
assembled from 37,427 Affymetrix U133 Plus 2.0 Array samples for enrichment in tissue/cell 
type expression (42). 
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Legends to figures 
Figure 1 Manhattan plot of results of the discovery meta-analysis of 20 studies 
Chromosomes are shown on the x-axis, the –log10 of the P-value on the y-axis. The grey dotted 
line represents the genome-wide significance cutoff of 5 x 10-8. Genes shown in black are the 
known loci that were significantly associated with childhood BMI in the joint discovery and 
replication analysis. Genes shown in grey were significant in the discovery, but not in the joint 
discovery and replication analysis. * indicates novel loci that were significantly associated with 
childhood BMI in the joint discovery and replication analysis. See also Table 1. 
 
Figure 2 Regional plots of the three novel loci for childhood BMI  
On the x-axis the position of SNPs on the chromosome is shown. On the left y-axis is the –log10 
of the P-values from the discovery analysis, on the right y-axis is the estimated recombination 
rate (from HapMap), shown by the light blue line in the figure. The named SNP is the most 
significant SNP in the locus from the discovery meta-analysis. . The linkage disequilibrium of all 
SNPs with the most significant SNP is shown by the symbols, with dark grey diamonds 
indicating an R2 of ≥0.8, inversed dark grey triangles indicating an R2 of 0.6-0.8, dark grey 
triangles indicating an R2 of 0.4-0.6, dark grey circles indicating an R2 of 0.2-0.4, and light grey 
circles indicating an R2 of 0-0.2. Genes (from HapMap release 22) are plotted below the x-axis. 
 
Figure 3 Association of the weighted risk score with BMI  
Along the x axis, categories of the weighted risk score are presented, the mean standard 
deviation score (SDS)-BMI per group is shown on the right y axis, with the line representing the 
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regression of the mean SDS-BMI values on the categories of the weighted risk score. The left y 
axis represents the number of children in each risk score category, shown in the histogram. The 
P-value is derived from the analysis of the continuous risk score. Analysis was performed in the 
PIAMA Study (N =1955). 
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Tables 
Table 1 Results of the discovery, replication and joint analyses for 43 loci with P-values < 5 x 10-6 in the discovery phase  
 
SNP 
 
CHR Position Nearest gene EA/Non-EA EAFa Betaa SEa 
P-value 
discovery 
P-value 
replication 
P–value 
joint 
rs13130484b 4 44870448 GNPDA2 T/C 0.44 0.067 0.007 8.94 x 10-11 4.29 x 10-18 1.58 x 10-23 
rs11676272b 2 24995042 ADCY3 G/A 0.46 0.068 0.007 8.55 x 10-23 0.020 7.12 x 10-23 
rs4854349b 2 637861 TMEM18 C/T 0.83 0.090 0.009 6.00 x 10-21 0.005 5.41 x 10-22 
rs543874b 1 176156103 SEC16B G/A 0.20 0.077 0.009 2.38 x 10-17 8.77 x 10-4 2.20 x 10-19 
rs7132908b 12 48549415 FAIM2 A/G 0.39 0.066 0.008 4.99 x 10-19 0.043 1.57 x 10-18 
rs1421085b 16 52358455 FTO C/T 0.41 0.059 0.007 3.20 x 10-19 0.654 4.53 x 10-16 
rs12429545c 13 53000207 OLFM4 A/G 0.13 0.076 0.010 3.66 x 10-11 1.01 x 10-4 2.08 x 10-14 
rs987237b 6 50911009 TFAP2B G/A 0.19 0.062 0.009 3.81 x 10-13 0.224 1.80 x 10-12 
rs12041852b 1 74776088 TNNI3K G/A 0.46 0.046 0.007 1.77 x 10-10 0.142 2.28 x 10-10 
rs6567160b 18 55980115 MC4R C/T 0.23 0.050 0.008 4.06 x 10-12 0.996  1.21 x 10-9 
rs13253111 8 28117893 ELP3 A/G 0.57 0.042 0.007 4.13 x 10-9 0.114 4.89 x 10-9 
rs8092503 18 50630485 RAB27B G/A 0.27 0.045 0.008 8.55 x 10-8 0.034 8.17 x 10-9 
rs3829849b 9 128430621 LMX1B T/C 0.36 0.041 0.007 1.46 x 10-6 0.001 8.81 x 10-9 
rs13387838 2 206989692 ADAM23 A/G 0.04 0.139 0.025 2.40 x 10-8 0.306 2.84 x 10-8 
rs7550711d 1 109884409 GPR61 T/C 0.04 0.105 0.019 1.50 x 10-8 0.401 4.52 x 10-8 
rs17309930b 11 27705069 BDNF A/C 0.21 0.045 0.009 2.47 x 10-8 0.540 1.41 x 10-7 
rs2590942b 1 72657869 NEGR1 T/G 0.82 0.047 0.009 3.88 x 10-9 0.966 1.91 x 10-7 
rs13107325b 4 103407732 SLC39A8 T/C 0.07 0.081 0.016 1.19 x 10-8 0.970 3.79 x 10-7 
rs10151686b 14 29536217 PRKD1 A/G 0.04 0.096 0.019 1.50 x 10-6 0.109 6.99 x 10-7 
rs25832 5 66211438 LOC375449 A/G 0.71 0.039 0.008 2.41 x 10-6 0.177 1.62 x 10-6 
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rs7869969 9 95257268 FAM120A G/A 0.33 0.036 0.008 4.43 x 10-7 0.425 1.68 x 10-6 
rs11079830c 17 44037629 HOXB6  A/G 0.58 0.034 0.007 1.43 x 10-6 0.254 1.98 x 10-6 
rs4569924 5 153520218 GALNT10 T/C 0.43 0.032 0.007 4.06 x 10-7 0.823 3.48 x 10-6 
rs8046312b 16 19886835 GPR139 A/C 0.81 0.042 0.009 4.06 x 10-10 0.185 3.97 x 10-6 
rs1838856 2 113822060 PAX8 A/C 0.46 0.034 0.008 1.85 x 10-6 0.588 1.47 x 10-5 
rs633143 1 179716108 CACNA1E T/C 0.14 0.044 0.011 3.40 x 10-6 0.648 2.44 x 10-5 
rs4923207 11 24713901 LUZP2 T/G 0.79 0.039 0.010 1.60 x 10-6 0.834 3.52 x 10-5 
rs6971577 7 140350204 MRPS33 C/G 0.78 0.036 0.009 1.17 x 10-6 0.690 6.80 x 10-5 
rs10866069 3 64366964 ADAMTS9 T/C 0.17 0.041 0.011 3.05 x 10-6 0.687 8.43 x 10-5 
rs12457682 18 7216505 LAMA1 C/A 0.23 0.035 0.009 3.81 x 10-6 0.942 9.01 x 10-5 
rs11165675b 1 96812556 PTBP2 A/G 0.27 0.031 0.008 2.93 x 10-6 0.520 1.01 x 10-4 
rs12096993 1 217931859 SLC30A10 T/C 0.27 0.031 0.008 1.38 x 10-6 0.583 1.02 x 10-4 
rs760931 1 1637388 CDC2L1 C/G 0.93 0.103 0.027 3.15 x 10-6 0.160 1.27 x 10-4 
rs2968990 4 131098524 C4orf33 C/T 0.37 0.028 0.007 1.67 x 10-6 0.487 1.42 x 10-4 
rs1247117 10 120418792 C10orf46 G/A 0.11 0.040 0.011 3.47 x 10-6 0.339 2.62 x 10-4 
rs6580706 12 47959818 TUBA1C C/G 0.34 0.031 0.009 1.83 x 10-8 0.047 3.68 x 10-4 
rs8092620 18 41433991 SLC14A2 G/T 0.48 0.024 0.007 3.31 x 10-6 0.199 7.32 x 10-4 
rs188584 3 62675007 CADPS C/A 0.77 0.028 0.008 3.23 x 10-6 0.139 0.001 
rs4870949 8 126704776 TRIB1 T/C 0.07 0.164 0.054 3.13 x 10-10 0.061 0.002 
rs1573972 4 171559399 AADAT C/T 0.19 0.030 0.013 3.78 x 10-6 0.232 0.020 
rs214821 20 2258291 TGM3 T/C 0.02 0.479 0.208 3.38 x 10-6 0.575 0.021 
rs8084077 18 49532928 DCC T/C 0.73 0.014 0.008 3.47 x 10-6 2.72 x 10-5 0.062 
rs3845265 18 63690108 DSEL G/A 0.71 0.013 0.008 8.86 x 10-7 1.44 x 10-6 0.087 
a From joint analysis 
b Locus previously reported in (11) 
c Locus previously reported in (11, 16) 
d Locus previously reported in (9, 11) 
CHR: Chromosome; EA: Effect Allele; EAF: Effect Allele Frequency; SE: Standard Error 
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Abbreviations 
 
1000G – 1000 Genomes 
BMI – Body mass index 
CHR - Chromosome 
DEPICT – Data-Driven Expression Prioritized Integration for Complex Traits 
EA – Effect allele 
EAF – Effect allele frequency 
eQTL – Expression quantitative trait locus 
FDR – False discovery rate 
GWAS – Genome-wide association study 
LD – Linkage disequilibrium 
MAF – Minor allele frequency 
HWE – Hardy-Weinberg Equilibrium 
SDS – Standard deviation score 
SE – Standard error 
SNP – Single Nucleotide Polymorphism 
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